The Net Margin of Talis Biomedical Corp (TLIS) is -2905.67%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2023-12-31 | -2905.67% |
2022-12-31 | -2348.55% |
2021-12-31 | -2343.90% |
2020-12-31 | -833.15% |
2019-12-31 | -690.82% |
2018-12-31 | -892.76% |